作为17β-Hydroxysteroid脱酶10型的抑制剂的C-3类固醇半导体
Michaela Hanzlova1, Barbora Slavikova2, Marina Morozovova2
1Faculty of Science, Department of Chemistry, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic.
ACS omega
|March 18, 2024
概括
新的类固醇化合物旨在抑制与神经退行性疾病相关的酶17β-HSD10. 化合物22和23显示出强大的抑制作用,而化合物23在没有细胞毒性的细胞环境中显示出有效性.
科学领域:
- 生物化学 生物化学
- 酶学 是一种酶学.
- 药用化学 医学化学
背景情况:
- 17β-hydroxysteroid脱酶10型 (17β-HSD10) 是一种线粒体酶,对类固醇恒温至关重要.
- 17β-HSD10的失调与阿尔茨海默氏症和癌症等神经退行性疾病有关,强调了其治疗潜力.
- 准17β-HSD10为开发这些疾病的新疗法提供了一个有前途的战略.
研究的目的:
- 设计和合成新型类固醇衍生物作为17β-HSD10的潜在抑制剂.
- 为了评估这些化合物的抑制活性对净化重组17β-HSD10.
- 评估最强大的抑制剂的细胞活性和细胞毒性.
主要方法:
- 类固醇衍生物的设计和合成,在C-3位置使用酸性半替代剂.
- 使用纯重组17β-HSD10的酶分析来确定合成化合物的抑制度 (IC50).
- 对化合物23的基质独立抑制,细胞活性和HEK-293细胞中的细胞毒性进行评估.
主要成果:
- 化合物22和23成为最强大的抑制剂,其IC50值分别为6.95 ± 0.35 μM和5.59 ± 0.25 μM.
- 化合物23证明了17β-HSD10活性的广泛抑制,无论基质如何.
- 化合物23在HEK-293细胞中没有表现出细胞毒性,并且在细胞环境中有效抑制了17β-HSD10活性.
结论:
- 合成的类固醇化合物,特别是22和23,是17β-HSD10的有效抑制剂.
- 化合物23由于其强大的基质独立抑制和有利的细胞形状,显示出显著的前景.
- 这些发现支持开发类固醇化合物作为针对相关疾病17β-HSD10的可行的治疗方法.
相关概念视频
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Adrenergic Antagonists: ɑ and β-Receptor Blockers
446
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
446
Stability of Conjugated Dienes
3.4K
Introduction
A comparison of the enthalpies of hydrogenation of dienes reveals that conjugated dienes release less heat on hydrogenation, rendering them more stable than their nonconjugated analogs.
A comparison of the enthalpies of hydrogenation of dienes reveals that conjugated dienes release less heat on hydrogenation, rendering them more stable than their nonconjugated analogs.
3.4K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
245
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
245
Antihypertensive Drugs: Thiazide-Class Diuretics
625
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
625
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
631
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
631


